Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Analyses of human immune responses to Francisella tularensis identify correlates of protection
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk mikrobiologi.
Appili Therapeutics, NS, Halifax, Canada.
Visa övriga samt affilieringar
2023 (Engelska)Ingår i: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 14, artikel-id 1238391Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Francisella tularensis is the etiological agent of the potentially severe infection tularemia. An existing F: tularensis vaccine, the live vaccine strain (LVS), has been used to protect at-risk personnel, but it is not licensed in any country and it has limited efficacy. Therefore, there is a need of a new, efficacious vaccine. The aim of the study was to perform a detailed analysis of the characteristics of the human immune response to F. tularensis, since this will generate crucial knowledge required to develop new vaccine candidates. Nine individuals were administered the LVS vaccine and peripheral blood mononuclear cells (PBMC) were collected before and at four time points up to one year after vaccination. The properties of the PBMC were characterized by flow cytometry analysis of surface markers and intracellular cytokine staining. In addition, the cytokine content of supernatants from F. tularensis-infected PBMC cultures was determined and the protective properties of the supernatants investigated by adding them to cultures with infected monocyte-derived macrophages (MDM). Unlike before vaccination, PBMC collected at all four time points after vaccination demonstrated F. tularensis-specific cell proliferation, cytokine secretion and cytokine-expressing memory cells. A majority of 17 cytokines were secreted at higher levels by PBMC collected at all time points after vaccination than before vaccination. A discriminative analysis based on IFN-γ and IL-13 secretion correctly classified samples obtained before and after vaccination. Increased expression of IFN-γ, IL-2, and MIP-1β were observed at all time points after vaccination vs. before vaccination and the most significant changes occurred among the CD4 transient memory, CD8 effector memory, and CD8 transient memory T-cell populations. Growth restriction of the highly virulent F. tularensis strain SCHU S4 in MDM was conferred by supernatants and protection correlated to levels of IFN-γ, IL-2, TNF, and IL-17. The findings demonstrate that F. tularensis vaccination induces long-term T-cell reactivity, including TEM and TTM cell populations. Individual cytokine levels correlated with the degree of protection conferred by the supernatants. Identification of such memory T cells and effector mechanisms provide an improved understanding of the protective mechanisms against F. tularensis. mechanisms against F. tularensis.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2023. Vol. 14, artikel-id 1238391
Nyckelord [en]
F. tularensis, human correlates of protection, immune response, memory cells, vaccination
Nationell ämneskategori
Immunologi Mikrobiologi inom det medicinska området
Identifikatorer
URN: urn:nbn:se:umu:diva-215234DOI: 10.3389/fimmu.2023.1238391PubMedID: 37781364Scopus ID: 2-s2.0-85173061344OAI: oai:DiVA.org:umu-215234DiVA, id: diva2:1805291
Forskningsfinansiär
Region Västerbotten, RV-939171Region Västerbotten, RV-941049Tillgänglig från: 2023-10-16 Skapad: 2023-10-16 Senast uppdaterad: 2024-01-17Bibliografiskt granskad

Open Access i DiVA

fulltext(2645 kB)31 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 2645 kBChecksumma SHA-512
0d2203ae3dfc3759d8045e28aa985fe79bb2199c569d08a98ebee76b820bede2260b36f0fa7b4aa4b648c864dd4f05aa8c4f88d67a20f50f3d460a13386602c2
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Lindgren, HelenaEneslätt, KjellGolovliov, IgorSjöstedt, Anders

Sök vidare i DiVA

Av författaren/redaktören
Lindgren, HelenaEneslätt, KjellGolovliov, IgorSjöstedt, Anders
Av organisationen
Institutionen för klinisk mikrobiologi
I samma tidskrift
Frontiers in Immunology
ImmunologiMikrobiologi inom det medicinska området

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 31 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 103 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf